We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
-11.13%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$1.47B
AUM Growth
-$329M
Cap. Flow
-$115M
Cap. Flow %
-7.78%
Top 10 Hldgs %
25.26%
Holding
689
New
51
Increased
102
Reduced
416
Closed
118

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$15.6M
2
MMM icon
3M
MMM
+$6.69M
3
SLB icon
SLB Ltd
SLB
+$6.53M
4
KO icon
Coca-Cola
KO
+$5.62M
5
INTC icon
Intel
INTC
+$5.37M

Sector Composition

Rank Sector Weight
1 Healthcare 16.53%
2 Technology 15.06%
3 Financials 14.92%
4 Consumer Discretionary 11.3%
5 Consumer Staples 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
76
General Dynamics
GD
$105B
$3.17M 0.22%
20,198
-1,105
-5% -$198K
FIS icon
77
Fidelity National Information Services
FIS
$22.1B
$3.14M 0.21%
30,612
+885
+3% +$92.2K
ZTS icon
78
Zoetis
ZTS
$32.4B
$3.11M 0.21%
36,405
+3,030
+9% +$273K
ROST icon
79
Ross Stores
ROST
$81.6B
$3.11M 0.21%
37,385
-3,280
-8% -$297K
LIN icon
80
Linde
LIN
$226B
$3.09M 0.21%
+19,815
New +$3.13M
BKNG icon
81
Booking.com
BKNG
$156B
$3.06M 0.21%
+44,375
New +$3.25M
GS icon
82
Goldman Sachs
GS
$301B
$3.04M 0.21%
18,201
-5,140
-22% -$1.04M
USB icon
83
US Bancorp
USB
$99.4B
$3.01M 0.2%
65,782
-35,580
-35% -$1.83M
CVS icon
84
CVS Health
CVS
$123B
$2.99M 0.2%
45,662
+6,557
+17% +$489K
CTSH icon
85
Cognizant
CTSH
$25.6B
$2.98M 0.2%
+47,020
New +$3.27M
EMR icon
86
Emerson Electric
EMR
$87.5B
$2.96M 0.2%
49,490
+6,790
+16% +$458K
MU icon
87
Micron Technology
MU
$996B
$2.88M 0.2%
90,710
+13,860
+18% +$525K
ICE icon
88
Intercontinental Exchange
ICE
$84.1B
$2.85M 0.19%
37,890
+225
+0.6% +$17.2K
MET icon
89
MetLife
MET
$64.3B
$2.75M 0.19%
66,960
+2,840
+4% +$122K
TMO icon
90
Thermo Fisher Scientific
TMO
$214B
$2.74M 0.19%
12,225
+10,975
+878% +$2.57M
ORLY icon
91
O'Reilly Automotive
ORLY
$76.2B
$2.72M 0.18%
118,500
-29,400
-20% -$669K
AGN
92
DELISTED
Allergan plc
AGN
$2.72M 0.18%
20,350
+1,480
+8% +$243K
MPC icon
93
Marathon Petroleum
MPC
$84B
$2.71M 0.18%
45,949
+28,389
+162% +$1.94M
AMAT icon
94
Applied Materials
AMAT
$419B
$2.69M 0.18%
82,150
+16,425
+25% +$563K
PSX icon
95
Phillips 66
PSX
$82.4B
$2.57M 0.17%
29,824
+130
+0.4% +$12.7K
AMT icon
96
American Tower
AMT
$79.8B
$2.56M 0.17%
16,190
-1,000
-6% -$156K
COF icon
97
Capital One
COF
$135B
$2.54M 0.17%
33,575
+1,305
+4% +$113K
CNC icon
98
Centene
CNC
$31.7B
$2.48M 0.17%
43,064
+19,660
+84% +$1.32M
NEE icon
99
NextEra Energy
NEE
$176B
$2.46M 0.17%
56,600
-10,120
-15% -$443K
CI icon
100
Cigna
CI
$72.7B
$2.42M 0.16%
12,721
+4,256
+50% +$888K

Similar funds

Oakbrook Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Oakbrook Investments held 689 positions worth $1.47B, down 18% from $1.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Oakbrook Investments withdrew a net $115M in Q4 2018, closing 118 positions and reducing 416 holdings. Its most notable exit was Johnson Controls International, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Oakbrook Investments opened a new position in Cognizant worth $2.98M.

  • Oakbrook Investments's largest Q4 2018 buy was Cognizant: 47,020 shares worth $2.98M.
  • Oakbrook Investments added most to Mondelez International in Q4 2018, an estimated $15.6M increase.
  • Oakbrook Investments's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $17.5M.
  • Oakbrook Investments fully exited Johnson Controls International in Q4 2018, selling an estimated $19.3M.
  • Oakbrook Investments's ten largest holdings make up 25% of its $1.47B portfolio in Q4 2018.
  • Oakbrook Investments opened 51 new positions and closed 118 in Q4 2018.
  • Oakbrook Investments's portfolio value fell 18% quarter-over-quarter to $1.47B.

Based on Oakbrook Investments's 13F filing for Q4 2018, filed 17 Jan 2019.